학술논문

The effects of N-acetylcysteine on hepatic, hematologic, and renal parameters in cirrhotic patients: a randomized controlled trial.
Document Type
Article
Source
Gastroenterology & Hepatology from Bed to Bench. Autumn2023, Vol. 16 Issue 4, p432-440. 9p.
Subject
*ACETYLCYSTEINE
*DRUG efficacy
*KIDNEYS
*BLOOD urea nitrogen
*LIVER
*CIRRHOSIS of the liver
*DIETARY supplements
*RANDOMIZED controlled trials
*PRE-tests & post-tests
*COMPARATIVE studies
*TREATMENT effectiveness
*BLIND experiment
*STATISTICAL sampling
*CREATININE
*EVALUATION
Language
ISSN
2008-2258
Abstract
Aim: To evaluate the effects of N-acetylcysteine (NAC) supplementation in cirrhotic patients. Background: Chronic hepatic inflammation leads to fibrosis and cirrhosis through various mechanisms such as oxidative stress. NAC is one of the intracellular precursors of glutathione that can degrade most reactive oxygen species. Recently, the beneficial effects of NAC in animal and human studies on preventing liver injury progression and improving liver function have been examined. However, more studies on human subjects are still required. Methods: Well-known cirrhotic patients with a specific etiology and aged 18 to 70 years who referred to the gastrointestinal clinic of Ayatollah Taleghani Hospital from December 2018 to December 2019 were enrolled in the present randomized double-blind controlled trial. Patients in the intervention group received NAC tablets at a dose of 600 mg daily, and the control group received a placebo. Demographic data, medical characteristics, and Child-Pugh and MELD scores evaluated at baseline and after 6 months. Results: Totally, 60 patients completed the present study (30 patients in the intervention group, and 30 patients in the control group). Hematological and biochemical parameters were normal in both groups with no significant differences at baseline and 6 months after intervention values. Moreover, the renal function indicators including serum creatinine (Cr) and urea (BUN) decreased significantly after intervention. Hepatic parameters also decreased significantly 6 months after intervention. Decreases in the renal and hepatic parameters 6 months after baseline in the control group were not statistically significant. Conclusion: The results of this study showed that NAC improved hepatic and renal function by decreasing serum urea and creatinine levels but had no significant effect on hematological and biochemical parameters. Furthermore, NAC significantly improved hepatic profiles by decreasing ALT, AST, and ALP in the liver enzymes between the intervention and control groups. Moreover, NAC caused a significant decrease in Child-Pugh and MELD scores. [ABSTRACT FROM AUTHOR]